Risk Reduction to Disease Management: Clinical Pharmacists as Cardiovascular Care Providers

被引:4
作者
Di Palo, Katherine E.
Patel, Khusbu
Kish, Troy
机构
关键词
EMERGENCY-MEDICINE PHARMACIST; TO-NEEDLE TIME; HEART-FAILURE; RANDOMIZED-TRIAL; MYOCARDIAL-INFARCTION; PATIENT-OUTCOMES; AMERICAN-COLLEGE; UNITED-STATES; IMPACT; SMOKING;
D O I
10.1016/j.cpcardiol.2018.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most cardiovascular diseases are caused by modifiable risk factors yet prevalence continues to increase and heart disease remains the leading cause of death in the United States. Screening, identifying and appropriately managing high risk patients are strategies to shift the paradigm from treatment to prevention. Pharmacists are an underutilized population health resource despite robust evidence to support their roles as interdisciplinary team members and direct patient care providers in both inpatient and outpatient settings. This article aims to highlight the multifaceted function and impact of clinical pharmacists on cardiovascular risk reduction and disease management.
引用
收藏
页码:276 / 292
页数:17
相关论文
共 79 条
[71]   DRUG-RELATED PROBLEMS - THEIR STRUCTURE AND FUNCTION [J].
STRAND, LM ;
MORLEY, PC ;
CIPOLLE, RJ ;
RAMSEY, R ;
LAMSAM, GD .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (11) :1093-1097
[72]   Pharmacist-led intervention in the multidisciplinary team approach optimizes heart failure medication [J].
Suzuki, Masanori ;
Matsue, Yuya ;
Izumi, Sayaka ;
Kimura, Ayako ;
Hashimoto, Tomoaki ;
Otomo, Kentaro ;
Saito, Hiroshi ;
Suzuki, Makoto ;
Kato, Yasuhisa ;
Funakoshi, Ryohkan .
HEART AND VESSELS, 2018, 33 (06) :615-622
[73]  
Taveira Tracey H, 2006, Prev Cardiol, V9, P202, DOI 10.1111/j.1520-037X.2006.05339.x
[74]   Low Adoption of Weight Loss Medications: A Comparison of Prescribing Patterns of Antiobesity Pharmacotherapies and SGLT2s [J].
Thomas, Catherine E. ;
Mauer, Elizabeth A. ;
Shukla, Alpana P. ;
Rathi, Samrat ;
Aronne, Louis J. .
OBESITY, 2016, 24 (09) :1955-1961
[75]   A randomized trial of a community-based approach to dyslipidemia management: Pharmacist prescribing to achieve cholesterol targets (RxACT Study) [J].
Tsuyuki, Ross T. ;
Rosenthal, Meagen ;
Pearson, Glen J. .
CANADIAN PHARMACISTS JOURNAL, 2016, 149 (05) :283-292
[76]   The Effectiveness of Pharmacist Interventions on Cardiovascular Risk The Multicenter Randomized Controlled RxEACH Trial [J].
Tsuyuki, Ross T. ;
Al Hamarneh, Yazid N. ;
Jones, Charlotte A. ;
Hemmelgarn, Brenda R. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (24) :2846-2854
[77]   Next Generation of Weight Management Medications: Implications for Diabetes and CVD Risk [J].
Wharton, S. ;
Serodio, K. J. .
CURRENT CARDIOLOGY REPORTS, 2015, 17 (05)
[78]  
WILT VM, 1995, PHARMACOTHERAPY, V15, P732
[79]   The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): Rationale for a Tailored Behavioral and Educational Pharmacist-Administered Intervention for Achieving Cardiovascular Disease Risk Reduction [J].
Zullig, Leah L. ;
Melnyk, S. Dee ;
Stechuchak, Karen M. ;
McCant, Felicia ;
Danus, Susanne ;
Oddone, Eugene ;
Bastian, Lori ;
Olsen, Maren ;
Edelman, David ;
Rakley, Susan ;
Morey, Miriam ;
Bosworth, Hayden B. .
TELEMEDICINE AND E-HEALTH, 2014, 20 (02) :135-143